V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290008207 | 290005047 | 1.63 | 49.2 | Curative (C) | 2017-01-04 | 2017-04-10 | MITOMYCIN | N | N | 290020355 | CYTARABINE INTRATHECAL |
| 290008208 | 290005050 | 1.57 | 75.4 | null | 2018-11-18 | 2018-11-18 | CISPLATIN + RT | 02 | N | 290020367 | CETUXIMAB + RT |
| 290008209 | 290005052 | 1.85 | 58.8 | Palliative (P) | 2019-02-08 | 2019-02-17 | Cisplatin | N | N | 290020378 | CARBOPLATIN + DACARBAZINE |
| 290008210 | 290005061 | 1.79 | null | Palliative (P) | 2016-12-15 | 2016-12-16 | PACLITAXEL | N | N | 290020394 | CETUXIMAB + IRINOTECAN + MDG |
| 290008211 | 290005064 | 1.6 | 82.9 | Palliative (P) | 2015-12-01 | 2015-12-22 | TRASTUZUMAB | 02 | N | 290020400 | LANREOTIDE |
| 290008212 | 290005067 | 0 | 76.1 | Palliative (P) | 2015-05-20 | 2017-02-12 | Oxaliplatin + Raltitrexed | 02 | N | 290020421 | CETUXIMAB |
| 290008213 | 290005070 | 1.67 | 87.9 | Palliative (P) | 2017-09-24 | 2017-09-26 | BALLAD Trial | Y | N | 290020425 | CAPECITABINE |
| 290008214 | 290005076 | 1.75 | 96.1 | Palliative (P) | 2017-09-27 | 2017-10-08 | Cetuximab + Radiotherapy Maint | Y | N | 290020449 | INTERAACT TRIAL |
| 290008215 | 290005082 | 1.64 | 56.7 | Disease modification (D) | 2016-12-18 | 2017-01-02 | CISPLATIN + RT | 02 | N | 290020514 | BEVACIZUMAB |
| 290008216 | 290005090 | null | 68 | Palliative (P) | 2017-04-16 | 2017-04-17 | Everolimus 10mg | 02 | N | 290020545 | CARBOPLATIN + ETOPOSIDE |
| 290008217 | 290007149 | 1.87 | 74.2 | Curative (C) | 2017-06-02 | 2017-06-02 | Capecitabine + Mitomycin | N | N | 290020596 | CARBOPLATIN + ETOPOSIDE |
| 290008218 | 290007150 | null | null | Curative (C) | 2016-09-25 | 2017-03-20 | FLUOROURACIL + MITOMYCIN | N | N | 290020614 | R-EPOCH |
| 290008219 | 290005114 | 1.69 | null | Palliative (P) | 2017-04-24 | 2018-04-02 | Docetaxel | N | null | 290020635 | CAPECITABINE + CISPLATIN |
| 290008220 | 290007153 | 1.6 | 94.3 | Palliative (P) | null | 2017-07-18 | Bevacizumab + CAPECITABINE + OXALIPLATIN | null | N | 290020638 | CETUXIMAB |
| 290008221 | 290005125 | 1.74 | null | Palliative (P) | 2017-03-19 | 2017-03-19 | CARBOPLATIN + ETOPOSIDE | N | N | 290020664 | ABIRATERONE |
| 290008222 | 290005134 | null | 53.7 | null | 2015-05-22 | 2015-05-22 | Capecitabine | N | N | 290020691 | CAPECITABINE + MITOMYCIN |
| 290008223 | 290005136 | null | 63.5 | Palliative (P) | 2017-03-19 | 2017-03-19 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290020706 | CETUXIMAB + CISPLATIN + FU |
| 290008224 | 290005139 | 1.6 | 67 | Curative (C) | 2016-02-20 | 2016-02-23 | CAPECITABINE + OXALIPLATIN | null | N | 290020727 | CARBOPLATIN |
| 290008225 | 290005149 | null | 55.9 | Palliative (P) | 2017-01-10 | 2017-01-10 | MCX | 02 | N | 290020769 | CARBOPLATIN + PACLITAXEL |
| 290008226 | 290005166 | 1.52 | 76.9 | Palliative (P) | 2016-06-30 | 2016-10-05 | Cyclophosphamide + Docetaxel | 02 | N | 290020855 | ECX |
| 290008227 | 290005172 | 1.81 | null | Curative (C) | null | 2016-01-13 | TEMOZOLOMIDE | N | Y | 290020891 | CARBOPLATIN + RT |
| 290008228 | 290007180 | null | null | Palliative (P) | 2019-01-22 | 2019-02-06 | CompARE Trial | 02 | N | 290020928 | CARBOPLATIN + ETOPOSIDE |
| 290008229 | 290008478 | null | 115 | Neo-adjuvant (N) | 2016-02-24 | 2016-03-01 | Capecitabine | 2 | N | 290020929 | FLUOROURACIL + MITOMYCIN |
| 290008230 | 290005177 | null | 55.5 | Palliative (P) | 2014-12-07 | 2017-04-29 | MCX | N | N | 290020933 | SUNITINIB |
| 290008231 | 290005180 | 1.67 | 103 | Curative (C) | 2017-05-04 | 2018-04-21 | CAPECITABINE + OXALIPLATIN | 02 | N | 290020967 | CAPECITABINE + OXALIPLATIN |
| 290008232 | 290007188 | 1.8 | null | Palliative (P) | 2014-04-30 | 2014-05-03 | Cisplatin + Radiotherapy | 02 | N | 290021002 | LANREOTIDE |
| 290008233 | 290005188 | 1.55 | 65.3 | Palliative (P) | null | 2016-07-01 | Cisplatin + Etoposide po&iv 3 day | N | null | 290021015 | MELPHALAN |
| 290008234 | 290005190 | 1.9 | 86 | Palliative (P) | 2018-11-07 | 2019-05-07 | MCX | 2 | N | 290021019 | TRIAL |
| 290008235 | 290005194 | 1.6 | 92.2 | Palliative (P) | 2017-07-23 | 2017-08-13 | Capecitabine | 02 | N | 290021035 | CETUXIMAB |
| 290008236 | 290005203 | 1.8 | 78.1 | Adjuvant (A) | null | 2017-11-07 | Trabectedin | N | null | 290021099 | CAPECITABINE + OXALIPLATIN |
| 290008237 | 290005218 | 1.61 | null | null | 2014-12-12 | 2015-04-03 | Cisplatin | N | N | 290021172 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 290008238 | 290005222 | 1.66 | 49.9 | Curative (C) | 2018-06-08 | 2018-06-09 | Docetaxel | 02 | N | 290021177 | CARBOPLATIN + RT |
| 290008239 | 290005224 | 1.66 | null | Palliative (P) | 2015-06-25 | 2015-07-26 | Trial Unspecified | N | null | 290021181 | CAPECITABINE + OXALIPLATIN |
| 290008241 | 290005230 | null | 76.3 | Palliative (P) | 2013-10-22 | 2017-05-05 | CAPECITABINE + MITOMYCIN + RT | N | N | 290021221 | CARBO + FLUOROURACIL |
| 290008242 | 290005236 | 1.75 | null | Palliative (P) | 2015-12-20 | 2016-02-11 | Cisplatin + Radiotherapy | 02 | N | 290021248 | CAPECITABINE + IRINOTECAN |
| 290008244 | 290005250 | 1.56 | 76.9 | Palliative (P) | 2016-04-04 | 2016-04-04 | Cetuximab + FOLFIRI cycle1 | 02 | N | 290021292 | OCTREOTIDE |
| 290008245 | 290005252 | null | 36 | Palliative (P) | 2015-01-07 | 2016-08-04 | CAPECITABINE + MITOMYCIN + RT | 2 | N | 290021310 | CAPECITABINE |
| 290008246 | 290005259 | null | null | Palliative (P) | 2018-02-26 | 2018-07-20 | Capecitabine + Oxaliplatin 21day | N | N | 290021347 | MELPHALAN |
| 290008247 | 290005264 | 1.76 | 83.6 | Neo-adjuvant (N) | 2018-03-01 | 2018-03-27 | Capecitabine + Oxaliplatin 21day | 02 | Y | 290021387 | CISPLATIN |
| 290008248 | 290005266 | 1.52 | 65.6 | Curative (C) | null | 2016-03-14 | Cetuximab+Cisplatin+FU (> Cycle 2) | 02 | N | 290021389 | FLUOROURACIL + MITOMYCIN |
| 290008249 | 290007232 | 1.66 | 72.9 | Palliative (P) | 2015-03-04 | 2015-03-12 | FLUOROURACIL + MITOMYCIN | N | N | 290021425 | OCTREOTIDE |
| 290008250 | 290005280 | 1.65 | 58.4 | Neo-adjuvant (N) | 2018-02-21 | 2018-03-21 | NIVOLUMAB | 02 | N | 290021439 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290008251 | 290005285 | 1.73 | 61 | null | 2015-09-15 | 2015-09-29 | Capecitabine | 02 | N | 290021442 | MITOMYCIN |
| 290008252 | 290005298 | 1.78 | 55.3 | null | null | 2017-10-16 | CAPECITABINE + OXALIPLATIN | 02 | N | 290021522 | CETUXIMAB + RT |
| 290008253 | 290005301 | 1.74 | 69.2 | Palliative (P) | 2015-08-26 | 2015-09-09 | Paclitaxel 7 day | N | N | 290021527 | EOX |
| 290008254 | 290005310 | 1.71 | 70.7 | Palliative (P) | 2015-04-10 | 2015-06-03 | EOX | 02 | N | 290021576 | TRABECTEDIN |
| 290008255 | 290005316 | 1.52 | null | Palliative (P) | 2018-04-16 | 2018-05-30 | Brentuximab Vedotin | 2 | N | 290021596 | CAPECITABINE + CISPLATIN |
| 290008256 | 290005321 | 1.7 | 58.2 | Curative (C) | 2016-09-26 | 2016-09-26 | CETUXIMAB + CISPLATIN + FU | 02 | N | 290021610 | CETUXIMAB + RT |
| 290008257 | 290005324 | 1.61 | null | Disease modification (D) | 2018-11-03 | 2018-11-10 | CISPLATIN + RT | N | N | 290021635 | LANREOTIDE |
| 290008258 | 290007251 | null | 84.5 | null | 2017-12-28 | 2018-01-01 | INTERAACT trial | 02 | N | 290021638 | CETUXIMAB + RT |